akampioneer.com akampioneer.com

akampioneer.com

the akampioneer - news and opinions on innovation

investor relations, public relations, innovation communication, science communication, fundraising, biotech, life sciences, healthcare, media coverage, crisis communication, high tech, innovative, energy, biopharmaceuticals, nanotechnology, new materials, strategic reputation management, corporate communications, fundraising, venture capital

http://www.akampioneer.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR AKAMPIONEER.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 11 reviews
5 star
5
4 star
3
3 star
2
2 star
0
1 star
1

Hey there! Start your review of akampioneer.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

20 seconds

CONTACTS AT AKAMPIONEER.COM

Akampion

Ines-Regina Buth

Wilhelms●●●●●●●● Str. 34

Be●●in , 10551

DE

49.3●●●●2768
in●●@akampion.com

View this contact

Akampion

Ines-Regina Buth

Wilhelms●●●●●●●● Str. 34

Be●●in , 10551

DE

49.3●●●●2768
in●●@akampion.com

View this contact

1&1 Internet AG

Hostmaster EINSUNDEINS

Brau●●●●. 48

Kar●●●uhe , 76135

DE

49.●●●600
49.72●●●●●74248
ho●●●●●●●●@1und1.de

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2009 September 21
UPDATED
2013 September 22
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 14

    YEARS

  • 7

    MONTHS

  • 9

    DAYS

NAME SERVERS

1
ns65.1und1.de
2
ns66.1und1.de

REGISTRAR

1 & 1 INTERNET AG

1 & 1 INTERNET AG

WHOIS : whois.schlund.info

REFERRED : http://1and1.com

CONTENT

SCORE

6.2

PAGE TITLE
the akampioneer - news and opinions on innovation | akampioneer.com Reviews
<META>
DESCRIPTION
investor relations, public relations, innovation communication, science communication, fundraising, biotech, life sciences, healthcare, media coverage, crisis communication, high tech, innovative, energy, biopharmaceuticals, nanotechnology, new materials, strategic reputation management, corporate communications, fundraising, venture capital
<META>
KEYWORDS
1 investor relations
2 public relations
3 innovation communication
4 science communication
5 fundraising
6 biotech
7 life sciences
8 healthcare
9 media coverage
10 crisis communication
CONTENT
Page content here
KEYWORDS ON
PAGE
your search term,company news,food for thought,innovation radar,akampion meets…,curetis ag,follow the akampioneer,links,akampion,akampion @ storify,pages,imprint,memberships,recent posts,archives,select month
SERVER
Apache
POWERED BY
PHP/5.2.17
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

the akampioneer - news and opinions on innovation | akampioneer.com Reviews

https://akampioneer.com

investor relations, public relations, innovation communication, science communication, fundraising, biotech, life sciences, healthcare, media coverage, crisis communication, high tech, innovative, energy, biopharmaceuticals, nanotechnology, new materials, strategic reputation management, corporate communications, fundraising, venture capital

INTERNAL PAGES

akampioneer.com akampioneer.com
1

Akampion Meets… | the akampioneer

http://akampioneer.com/category/akampion-meets

Season s Greetings from akampion. Friday, December 18, 2015. Dear friends and colleagues,. As 2015 is coming to a close, we would like to take the opportunity to thank you for your continued support and wish you a relaxed, peaceful Christmas holiday and a Happy New Year! Our highlights in 2015 include Read more. The continued expansion of akampion s client base,. Strengthened strategic partnerships with colleagues in the U.S. to ensure optimum transatlantic communication programs for our clients,. If you...

2

Food For Thought | the akampioneer

http://akampioneer.com/category/food-for-thought

Food for Thought: How to (Not? Create a Buzz With Your Corporate Press Release. Wednesday, May 30, 2012. This week, NYC-base d. Immune Response BioPharma, Inc. Announced that the company has terminated partnering discussions on its multiple sclerosis vaccine NeuroVax with GlaxoSmithKline. The news. Per se may not trigger a lot of interest – but the company has managed to create a significant buzz around its announcement, with CEO David Buswell stating that (quote from corporate press release):. Food for ...

3

ISA Pharmaceuticals Announces Start of First Phase I/II Clinical Trial of its SLP®-AMPLIVANT® Conjugates | the akampioneer

http://akampioneer.com/company-news/company-news-isa-pharmaceuticals-announces-start-of-first-phase-iii-clinical-trial-of-its-slp®-amplivant®-conjugates.html

Company News: ISA Pharmaceuticals Announces Start of First Phase I/II Clinical Trial of its SLP -AMPLIVANT Conjugates. Thursday, February 26, 2015. Leiden University Medical Center to study novel immunotherapeutic in HPV-positive head and neck cancer patients. ISA Pharmaceuticals B.V. S) covalently linked to AMPLIVANT. A synthetic Toll-like receptor (TLR) 1/2 ligand. The investigators have assigned the acronym HESPECTA to the conjugate (HPV E-Six Peptide Conjugated To AMPLIVANT. Conjugates have demonstra...

4

Anergis Presents Sustained Efficacy Data from its AllerT Phase IIb Trial at the AAAAI Annual Meeting | the akampioneer

http://akampioneer.com/company-news/company-news-anergis-presents-sustained-efficacy-data-from-its-allert-phase-iib-trial-at-the-aaaai-annual-meeting.html

Company News: Anergis Presents Sustained Efficacy Data from its AllerT Phase IIb Trial at the AAAAI Annual Meeting. Monday, February 23, 2015. Contiguous Overlapping Peptide allergy immunotherapeutic AllerT confirms sustained efficacy in the second year following treatment. A company developing novel and proprietary ultra-fast allergy immunotherapeutics, presented detailed data from the Phase IIb trial of its birch pollen allergy immunotherapeutic AllerT in two separate scientific posters at the AAAAI (.

5

Curetis to Launch Next-Generation Pneumonia Application at ECCMID 2015 | the akampioneer

http://akampioneer.com/company-news/company-news-curetis-to-launch-next-generation-pneumonia-application-at-eccmid-2015.html

Company News: Curetis to Launch Next-Generation Pneumonia Application at ECCMID 2015. Thursday, April 16, 2015. Company Successfully Completes Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application. Clinical sensitivity across 40-marker panel averages 94% at 99.4% specificity. The Unyvero P55 Pneumonia Application demonstrates superiority over culture and key enhancements compared to the P50 cartridge, evidenced by pathogen and resistance expansions and improved sensitivity proven in the...

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

mobilgesund.com mobilgesund.com

:: akampion :: we create visibility

http://www.mobilgesund.com/akampion.php

Telling your company s story is not an easy job - but it is crucial for reaching your corporate goals. Wouldn t it be great to find a committed partner to define and convey your story in a powerful way? Someone who provides you with a fresh, un-biased perspective and successfully connects you to corporate partners, the media and the investment community? And Head of Investor Relations at Micromet. Subscribe to news updates. Follow us on twitter.

mobilgesund.com mobilgesund.com

:: akampion :: we create visibility

http://www.mobilgesund.com/imprint.php

Lübecker Str. 28. 10559 Berlin, Germany. Tel: 49 (0)30 2363 2768. Dr Ludger Weß. 22587 Hamburg, Germany. Tel: 49 (0)40 8816 5964. Editorial: Ines-Regina Buth, Dr. Ludger Weß. E-Mail: info(at)akampion.com. Design and Programming: Design Direction. Subscribe to news updates. Follow us on twitter.

mobilgesund.com mobilgesund.com

:: akampion :: we create visibility

http://www.mobilgesund.com/disclaimer.php

Contents of the web site. Links to third party information. The akampion web site links to third party information providers. Ines-Regina Buth and Ludger Wess have no influence on the contents or reliability of the web sites of these third party information providers. The following therefore applies to all links:. The declaration is valid for all links given on our web site and the material of all sites reached via banners and links on the akampion web site. Subscribe to news updates. Follow us on twitter.

ir-buth.com ir-buth.com

:: akampion :: we create visibility

http://www.ir-buth.com/index.php

Please click here to subscribe to regular news updates from the akampioneer.com. Friday, August 19, 2016. Company News: Curetis Reports Financial Results for the First Six Months of 2016. Key business and commercial milestones and goals met. Global presence further strengthened with subsidiaries in the U.S., UK, France and the Netherlands. The “ Company. 8221; and, together with Curetis GmbH, “ Curetis. Operational and Business Highlights 2016 to Date. Tuesday, August 16, 2016. The accreditation comes fr...

ir-buth.com ir-buth.com

:: akampion :: we create visibility

http://www.ir-buth.com/services.php

Akampion is a communication consultancy with a dedicated approach to building a strong reputation for their clients called Triple C approach. We create, convey. We create powerful corporate stories for our clients, convey these stories and messages to the right target audience and connect our clients to key decision makers. Subscribe to news updates. Follow us on twitter.

ir-buth.com ir-buth.com

:: akampion :: we create visibility

http://www.ir-buth.com/clients.php

We will be your partner. Since its foundation in late 2006, akampion has built a strong client roster of private and. Public companies in the biopharmaceutical, medtech, diagnostics, high-tech and investment industries. Please click on the sections below to see the full client list. Please feel free to contact us for references and case studies: info(at)akampion.com. Subscribe to news updates. Follow us on twitter.

ir-buth.com ir-buth.com

:: akampion :: we create visibility

http://www.ir-buth.com/imprint.php

Lübecker Str. 28. 10559 Berlin, Germany. Tel: 49 (0)30 2363 2768. Dr Ludger Weß. 22587 Hamburg, Germany. Tel: 49 (0)40 8816 5964. Editorial: Ines-Regina Buth, Dr. Ludger Weß. E-Mail: info(at)akampion.com. Design and Programming: Design Direction. Subscribe to news updates. Follow us on twitter.

ir-buth.com ir-buth.com

:: akampion :: we create visibility

http://www.ir-buth.com/disclaimer.php

Contents of the web site. Links to third party information. The akampion web site links to third party information providers. Ines-Regina Buth and Ludger Wess have no influence on the contents or reliability of the web sites of these third party information providers. The following therefore applies to all links:. The declaration is valid for all links given on our web site and the material of all sites reached via banners and links on the akampion web site. Subscribe to news updates. Follow us on twitter.

akampion.com akampion.com

:: akampion :: we create visibility

http://www.akampion.com/imprint.php

Lübecker Str. 28. 10559 Berlin, Germany. Tel: 49 (0)30 2363 2768. Dr Ludger Weß. 22587 Hamburg, Germany. Tel: 49 (0)40 8816 5964. Editorial: Ines-Regina Buth, Dr. Ludger Weß. E-Mail: info(at)akampion.com. Design and Programming: Design Direction. Subscribe to news updates. Follow us on twitter.

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL LINKS TO THIS WEBSITE

22

SOCIAL ENGAGEMENT



OTHER SITES

akampharma.com akampharma.com

AkamPharma | Home

A Clear Vision Is Our Mission. Health also refers to the general wellness. A Clear Vision Is Our Mission. Akam Darou mission leads what we do. progressing focuses on Akam Darous Promoting, positive and targeted method as we look forward. Health shows a wide commitment to health services, supported by a large range of products that help improve the welfare state of patients around the country. health also refers to the general wellness of our customers, employees and communities. Middle income countries f...

akamphysics10.blogspot.com akamphysics10.blogspot.com

MYP PHYSICS

This is our year 10 myp blog. We can use it to share our learning experiences. Sunday, June 3, 2012. How can physics improve car safety? Read the document (http:/ www.who.int/world-health-day/previous/2004/en/traffic facts en.pdf), WHO Road Traffic Injuries, below. State the problem/issue that physicists are able to address using this process. Explain how physics can be used to solve this problem. Explain any benefits and limitations of using this process. Assessment Criteria One World A. The student sta...

akamphyzics.blogspot.com akamphyzics.blogspot.com

MYP PHYSICS

All science is either physics or stamp collecting -Lord Kelvin. Sunday, January 8, 2012. You are a travel company advertising trips into space to visit the planets in the solar system. Your task is to choose one of the planets in the solar system and use the internet, books and any other resource to find out as much as you can about that particular planet. You should then. Make this as fun as possible. Remember you are trying to attract them to the planet so that they take their holiday there! Other proj...

akampictures.com akampictures.com

AKAM PICTURES - Wedding Cinematography

akampion.com akampion.com

:: akampion :: we create visibility

Please click here to subscribe to regular news updates from the akampioneer.com. Tuesday, May 12, 2015. Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. Monday, May 11, 2015. Company News: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer. A developer of next-level molecular diagnostic solu...

akampioneer.com akampioneer.com

the akampioneer - news and opinions on innovation

Company News: New Peer-Reviewed Publication Provides Further Insights into Mechanism of ISA Pharmaceuticals’ SLP Immunotherapeutics. Tuesday, May 12, 2015. SLP s modulate intratumoral macrophages required for tumor regression. ISA Pharmaceuticals B.V. A clinical-stage immunotherapy company focusing on rationally designed immunotherapeutics against cancer and persistent viral infections, today announced the publication of a new peer-reviewed paper*. Posted in Company News. Monday, May 11, 2015. A develope...

akampita.com akampita.com

Akampita | Connecting Mind, Body and Soul

Akampita is a MQA. Approved training centre which provides an array of tailor made training programs addressing the short and long terms requirements of the local industries. Akampita Yoga Weekend Retreat in Mauritius Program. Know before you go. Blog, News & Events. The 'Curing through Yoga Retreat program' was an excellent initiative to discover the wonders of Yoga within few lessons. Is a MQA approved training centre designed to address new skills gaps in the corporate world. Latest News and Events.

akampitasteiner.de akampitasteiner.de

°°° Akampita Steiner - eine Ausnahme-Künstlerin °°°

Töne durch Seele bewegt. Seele in Worte gelegt. Körper durch Seele, Töne und Worte gelebt. Obertongesang, Konzertgitarre, Chanson, Improvisation,. Rezitation, Flöten, Monochord, Lyrik.

akampo.com akampo.com

『祥仁漢方薬店』正規品は保証します!

今月 0401-04.30 当店で買い物すれば、 風油精 スイセン 6ml 1本をお客様にプレゼントいたします。 携帯URL http:/ www.okampo.com/i/.

akampot.com akampot.com

А кампот? Субъективный ресторанный блог гастрономической путешественницы

Рекомендационный субъективный (и полезный) ресторанный блог гастрономической путешественницы (и ее друзей;). Список мест по городам. Когда вы путешествуете, вы же, наверное, хотите кушать только в проверенных, рекомендованных и хороших местах? Блог вам в помощь, друзья! Коммерческий директор 1 1 media group. 16 мая, 23:00, Алгавре. Остров Самуи. Район Чавенг. Глава организации БФ "Центр допомоги". Group CEO of Havas Worldwide Ukraine. 15 мая, 10:00, Самуй. Must Be рестораны Лос Анджелеса, часть вторая:.

akamps.com akamps.com

کار در ارتفاع, کار با طناب, کار در ارتفاع بدون داربست - آکام پوشش شهر

پیچ و رول پلاک. کار بر روی سکوهای نفتی. پروژه های انجام شده. جهت مشاوره رایگان و یا سفارش پروژه با ما در تماس باشید. تلفن: 2 - 77684171. شرکت آکام پوشش شهر(APS). شرکت آکام پوشش شهر(APS). با بهره گیری از فناوری روز و با در اختیار داشتن تیم طراحی و مهندسی کار آمد و گروه های زبده اجرایی توانایی ارائه خدمات در سراسر کشوررا دارد و مجموعه ای توانمند را تشکیل داده است که با رعایت اصل مشتری مداری افق روشنی را در جهت ارتقاء سطح کیفی مهندسی ساختمان را به تصویر می کشد. رنگ آمیزی سکوهای نفتی. فاقد صدای نا هنجار و ما...